Moderna Phase III COVID-19 Vaccine Plan To Enroll 30,000 Patients

 
• By Jessica Merrill

The company finalized the Phase III program based on feedback from the US FDA and plans to start the study in July. With a 100 µg dose, Moderna says it can manufacture 500 million doses a year.

Motion blurred racetrack,sunset scene
Moderna is moving a COVID-19 vaccine quickly into Phase III • Source: Shutterstock

More from COVID-19

More from Scrip